• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Health Catalyst Announces New Leadership Assignments in Support of Strategic Focus Areas

    9/7/22 4:00:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology
    Get the next $HCAT alert in real time by email

    Announces Appointments of Kevin Freeman as Chief Growth Officer, Tarah Neujahr Bryan as Chief Marketing Officer, and Dave Ross as Chief Technology Officer

    SALT LAKE CITY, Sept. 7, 2022 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced three new leadership assignments in support of its strategic focus areas moving forward. These strategic focus areas center around strengthening and deepening existing client relationships to enable greater success in realizing massive, measurable, data-informed improvement while continuing to add new client relationships.

    (PRNewsfoto/Health Catalyst)

    This strategic focus includes the appointment of the company's current Chief Revenue Officer, Kevin Freeman, as Chief Growth Officer, and current Chief Brand and Communications Officer, Tarah Neujahr Bryan, as Chief Marketing Officer, effective September 7, 2022. In these roles, Kevin and Tarah will be responsible for the strategic growth functions at Health Catalyst, with a primary focus on expanding existing client relationships, and Kevin and Tarah will each report directly to Chief Executive Officer Dan Burton.

    Kevin Freeman came to Health Catalyst in 2020 as part of the Vitalware acquisition, bringing 20+ years of healthcare IT growth leadership experience including publicly traded, private equity, and venture-capital-backed companies. He has a successful track record of building results-driven teams, strengthening client partnerships, and driving business development growth. Kevin has a Bachelor of Arts in Sociology from the University of Texas at Arlington.

    Tarah Neujahr Bryan joined Health Catalyst in 2013 and has served as Editorial Director, Senior Vice President of Marketing, and Chief Brand and Communications Officer. She brings a breadth of marketing and communications experience to her current role. Prior to joining Health Catalyst, Tarah served as the Marketing Communications Director and the Foundation Executive Director at a community hospital, managed at an advertising agency, was the Editor and Operations Manager at an archaeology firm, and provided triage assistance and patient admissions at a Level-II Trauma Center. She has a Master of Arts in Journalism and Mass Communications from the University of Nebraska and a Bachelor of Arts from Montana State University-Billings.

    Health Catalyst has also named Dave Ross, current Associate Chief Technology Officer, as Chief Technology Officer, also effective September 7, 2022. He will play a critical technology leadership role in building and enabling a world-class data and analytics infrastructure to support clients' efforts towards massive improvement in critical use-case areas such as tech-enabled outsourcing, financial empowerment, population health, and clinical improvement.

    Dave Ross joined Health Catalyst in 2021 as part of the Twistle acquisition, and was previously the Chief Technology Officer and Co-Founder of Twistle, leading all product development and engineering activities for over ten years prior to Twistle being acquired by Health Catalyst. Before starting Twistle, Dave was the Director of Information Systems at Albany Medical Center in New York. He has built and led software development initiatives across healthcare and educational technology sectors and is passionate about finding the perfect intersection between engineering excellence and delivering business value. Dave holds a Bachelor of Science in Information Systems from SUNY Empire State College.

    "This is a pivotal time for Health Catalyst as we work toward enabling the positive transformation of care for every patient served by our healthcare clients," said Chief Executive Officer Dan Burton. "I am grateful for each of these three world-class leaders moving into key positions, providing them with an increased opportunity to deliver on our long-term growth and vision to sustain our critical mission of being a catalyst, in deep partnership with our clients, to enable massive, measurable, data-informed healthcare improvement."

    Related to the new growth leadership assignments, effective September 30, 2022, Patrick Nelli will transition from his role as President to that of Senior Advisor, where he will primarily focus on enabling a smooth transition of his prior responsibilities as President to Kevin Freeman, Chief Growth Officer, and to Dan Burton, Chief Executive Officer. Patrick joined Health Catalyst in 2013 and has played various roles contributing to the company's success, including as Chief Financial Officer from 2017 to January 2021, and as President from January 2021 to the present. Also, effective September 30, 2022, Bryan Hinton will complete his tenure at Health Catalyst. Bryan has contributed to Health Catalyst's growth and success in a number of roles since he joined the company in 2012, including most recently in the role of Chief Technology Officer. 

    Dan Burton shared, "I want to extend my heartfelt gratitude to Patrick and to Bryan for their many years of service and dedication to our mission, and for their incredible expertise and leadership in various roles over the years. They have deeply contributed to our company's mission, growth, and success. We are truly grateful to these outstanding colleagues, and we wish them continued success in their future endeavors."

    About Health Catalyst

    Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its clients leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

    Media Contact:

    Tarah Neujahr Bryan, Chief Marketing Officer

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/health-catalyst-announces-new-leadership-assignments-in-support-of-strategic-focus-areas-301619705.html

    SOURCE Health Catalyst

    Get the next $HCAT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HCAT

    DatePrice TargetRatingAnalyst
    8/11/2025Buy → Neutral
    Citigroup
    8/8/2025$4.00Overweight → Neutral
    Cantor Fitzgerald
    6/17/2025Buy → Neutral
    BTIG Research
    4/9/2025Outperform → In-line
    Evercore ISI
    1/8/2025$9.00Sector Weight → Overweight
    KeyBanc Capital Markets
    4/10/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    1/3/2024$14.00Overweight
    Barclays
    1/3/2024$11.00In-line → Outperform
    Evercore ISI
    More analyst ratings

    $HCAT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Health Catalyst downgraded by Citigroup

    Citigroup downgraded Health Catalyst from Buy to Neutral

    8/11/25 9:56:17 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst downgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald downgraded Health Catalyst from Overweight to Neutral and set a new price target of $4.00

    8/8/25 8:19:52 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst downgraded by BTIG Research

    BTIG Research downgraded Health Catalyst from Buy to Neutral

    6/17/25 7:47:53 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $HCAT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Smith S. Dawn was granted 36,231 shares, increasing direct ownership by 55% to 101,692 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    7/11/25 4:01:06 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Director Gallagher Duncan was granted 36,231 shares, increasing direct ownership by 47% to 113,282 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    7/10/25 8:17:34 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Director Hoggard Green Jill was granted 36,231 shares, increasing direct ownership by 131% to 63,937 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    7/10/25 8:17:24 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Burton Daniel D. bought $204,525 worth of shares (26,200 units at $7.81), increasing direct ownership by 2% to 1,172,623 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    2/27/24 4:01:39 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Health Catalyst Announces CEO Dan Burton to Step Down to Pursue Service Opportunities

    Mr. Burton to Retire June 30, 2026, Actively Committed to Support Board in Transition and New CEO Search SALT LAKE CITY, Aug. 7, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Health Catalyst Chief Executive Officer Dan Burton is stepping down from his role as CEO, effective June 2026, to enable additional time to pursue a few volunteer service opportunities he and his wife will participate in, in support of their faith, as active members of the Church of Jesus Christ of Latter-Day Saints.

    8/7/25 4:38:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Reports Second Quarter 2025 Results

    SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2025. "For the second quarter of 2025, I am pleased by our strong financial results, including total revenue of $80.7 million and Adjusted EBITDA of $9.3 million, with these results beating our quarterly guidance on each metric." said Dan Burton, CEO of Health Catalyst. "I also want to share my plan to retire from the CEO role at Health Catalyst effective June 30, 2026. By then, I will have been leading Health Catalyst full-time

    8/7/25 4:03:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025

    SALT LAKE CITY, July 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2025 operating results on Thursday, August 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ225." A live audio webcast will be available online at https://ir.healthcatalyst.com/.

    7/17/25 8:30:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    SEC Filings

    View All

    SEC Form 10-Q filed by Health Catalyst Inc

    10-Q - Health Catalyst, Inc. (0001636422) (Filer)

    8/8/25 4:13:06 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - Health Catalyst, Inc. (0001636422) (Filer)

    8/7/25 4:11:16 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Health Catalyst, Inc. (0001636422) (Filer)

    7/10/25 5:26:18 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Leadership Updates

    Live Leadership Updates

    View All

    Ardent Health Appoints Robert DeMichiei to Board of Directors

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U

    4/3/25 5:27:00 PM ET
    $AP
    $ARDT
    $HCAT
    Fluid Controls
    Industrials
    Hospital/Nursing Management
    Health Care

    Modern Health Welcomes Adam Brown as Chief Financial Officer

    Strengthens Executive Team with Seasoned Healthcare Finance Leader Modern Health, a leading global workplace mental health platform, today announces the appointment of Adam Brown as Chief Financial Officer. With an extensive background in healthcare finance and operations, including significant experience scaling high-growth healthcare technology companies, Brown brings deep industry expertise to the company. "Adam is a valued addition to Modern Health's leadership team, and we are thrilled to welcome him on board. His impressive track record and deep understanding of both public and private markets strengthens our executive bench as we continue to execute our vision," said Gyre Renwick

    1/15/25 10:16:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare Services

    SALT LAKE CITY, Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has signed a definitive agreement to acquire Upfront Healthcare Services, Inc. ("Upfront"), a next-generation patient engagement platform provider. Health Catalyst anticipates the acquisition will close in the first quarter of 2025.Upfront provides a market-leading patient activation and engagement platform and a proprietary strategic marketing analytics and content personalization solution for healthcare enterprises. Upfront's automated patient acquisition and retention solu

    1/13/25 8:00:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Financials

    Live finance-specific insights

    View All

    Health Catalyst Reports Second Quarter 2025 Results

    SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2025. "For the second quarter of 2025, I am pleased by our strong financial results, including total revenue of $80.7 million and Adjusted EBITDA of $9.3 million, with these results beating our quarterly guidance on each metric." said Dan Burton, CEO of Health Catalyst. "I also want to share my plan to retire from the CEO role at Health Catalyst effective June 30, 2026. By then, I will have been leading Health Catalyst full-time

    8/7/25 4:03:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025

    SALT LAKE CITY, July 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2025 operating results on Thursday, August 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ225." A live audio webcast will be available online at https://ir.healthcatalyst.com/.

    7/17/25 8:30:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Reports First Quarter 2025 Results

    SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025. "For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly guidance on each metric," said Dan Burton, CEO of Health Catalyst. "Additionally, we are happy to share that we added 10 net new Platform Clients in Q1 2025. This is especially encouraging given that Q1 is typically a quieter bo

    5/7/25 4:03:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

    SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

    11/14/24 7:51:57 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    SEC Form SC 13G filed by Health Catalyst Inc

    SC 13G - Health Catalyst, Inc. (0001636422) (Subject)

    11/14/24 4:44:34 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

    SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

    11/12/24 3:55:05 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology